| Primary |
| Contraception |
59.0% |
| Drug Use For Unknown Indication |
10.4% |
| Product Used For Unknown Indication |
5.6% |
| Menstruation Irregular |
3.2% |
| Acne |
2.8% |
| Colitis Ulcerative |
2.8% |
| Oral Contraception |
2.5% |
| Asthma |
1.6% |
| Anxiety |
1.2% |
| Blood Pressure |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Ovarian Cyst |
1.2% |
| Convulsion |
0.9% |
| Cough |
0.9% |
| Depression |
0.9% |
| Hypersensitivity |
0.9% |
| Inflammatory Bowel Disease |
0.9% |
| Polycystic Ovaries |
0.9% |
| Renal Transplant |
0.9% |
| Routine Health Maintenance |
0.9% |
|
| Pregnancy On Oral Contraceptive |
49.3% |
| Pulmonary Embolism |
7.8% |
| Coeliac Disease |
6.0% |
| Thrombosis |
4.1% |
| Vomiting |
4.1% |
| Off Label Use |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.2% |
| Urinary Tract Infection |
2.8% |
| Vaginal Haemorrhage |
2.8% |
| Metrorrhagia |
2.3% |
| Nausea |
2.3% |
| Drug Dose Omission |
1.4% |
| Paget-schroetter Syndrome |
1.4% |
| Paralysis |
1.4% |
| Pyrexia |
1.4% |
| Surgery |
1.4% |
| Therapeutic Response Unexpected |
1.4% |
| Weight Increased |
1.4% |
| Chest Discomfort |
0.9% |
| Convulsion |
0.9% |
|
| Secondary |
| Contraception |
28.7% |
| Drug Use For Unknown Indication |
20.0% |
| Product Used For Unknown Indication |
10.0% |
| Oral Contraception |
9.1% |
| Menstruation Irregular |
5.7% |
| Polycystic Ovaries |
4.8% |
| Glucose Tolerance Impaired |
2.6% |
| Acne |
2.2% |
| Asthma |
2.2% |
| Blood Triglycerides Increased |
2.2% |
| Weight Decreased |
2.2% |
| Convulsion |
1.7% |
| Dysmenorrhoea |
1.3% |
| Menorrhagia |
1.3% |
| Muscle Spasms |
1.3% |
| Rhinitis Allergic |
1.3% |
| Anxiety |
0.9% |
| Blood Pressure |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hereditary Angioedema |
0.9% |
|
| Pregnancy On Oral Contraceptive |
25.3% |
| Unintended Pregnancy |
11.4% |
| Vomiting |
7.6% |
| Off Label Use |
6.3% |
| Skin Exfoliation |
6.3% |
| Thrombophlebitis Septic |
5.1% |
| Convulsion |
3.8% |
| Inappropriate Schedule Of Drug Administration |
3.8% |
| Multiple Sclerosis |
3.8% |
| Venous Injury |
3.8% |
| Cerebrovascular Accident |
2.5% |
| Drug Interaction |
2.5% |
| Metrorrhagia |
2.5% |
| Speech Disorder |
2.5% |
| Thirst |
2.5% |
| Treatment Noncompliance |
2.5% |
| Urinary Tract Infection |
2.5% |
| Vaginal Infection |
2.5% |
| Amenorrhoea |
1.3% |
| Cholelithiasis |
1.3% |
|
| Concomitant |
| Contraception |
25.8% |
| Acne |
15.8% |
| Product Used For Unknown Indication |
12.2% |
| Asthma |
5.4% |
| Oral Contraception |
5.2% |
| Crohn's Disease |
4.4% |
| Post Coital Contraception |
3.9% |
| Premenstrual Syndrome |
3.9% |
| Depression |
3.5% |
| Pain |
3.3% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Multiple Allergies |
2.5% |
| Menorrhagia |
1.8% |
| Multiple Sclerosis |
1.8% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Anxiety |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Headache |
1.3% |
| Hypersensitivity |
1.3% |
| Insomnia |
1.3% |
|
| Menstruation Irregular |
12.1% |
| Cholecystitis Chronic |
8.5% |
| Pain |
7.3% |
| Pulmonary Embolism |
7.3% |
| Cholelithiasis |
6.7% |
| Weight Decreased |
6.7% |
| Gallbladder Disorder |
4.8% |
| Rectal Haemorrhage |
4.8% |
| Headache |
4.2% |
| Injury |
4.2% |
| Viral Infection |
4.2% |
| Vomiting |
4.2% |
| Suicidal Ideation |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Abdominal Pain Upper |
3.0% |
| Nausea |
3.0% |
| Palpitations |
3.0% |
| Treatment Noncompliance |
3.0% |
| Urinary Tract Infection |
3.0% |
| Abdominal Pain |
2.4% |
|
| Interacting |
| Colitis Ulcerative |
43.4% |
| Product Used For Unknown Indication |
18.9% |
| Contraception |
9.4% |
| Cough |
9.4% |
| Inflammatory Bowel Disease |
9.4% |
| Vitamin Supplementation |
9.4% |
|
| Gastrointestinal Inflammation |
20.0% |
| Nephritis |
20.0% |
| Oropharyngeal Pain |
20.0% |
| Red Blood Cell Sedimentation Rate Increased |
20.0% |
| Stomatitis |
20.0% |
|
